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Unruptured Aneurysms with Cranial
Nerve Symptoms: Efficacy of
Endosaccular Guglielmi Detachable
Coil Treatment
Objective: To evaluate the efficacy of endosaccular Guglielmi detachable coil
(GDC) treatment of unruptured aneurysms causing cranial nerve (CN) symp-
toms.
Materials and Methods: Among a database of 218 patients whose aneurysms
were treated using GDC, seven patients met the criteria for unruptured
aneurysms presenting with symptoms and signs of CN palsy. Changes in CN
symptoms before and after GDC treatment were reviewed.
Results: Aneurysms were located in the internal carotid-posterior communicat-
ing artery (n=3), the basilar bifurcation (n=1) and the cavernous internal carotid
artery (n=3). CN symptoms included ptosis (n=6), mydriasis (n=2), and extraoc-
ular muscle (EOM) disorder (CN III: n=4; CN VI: n=3). Overall, improvement or
resolution of CN symptoms after treatment was noted in five patients. CN symp-
toms in cases involving small ( 10 mm) and intradural aneurysms tended to
respond better to GDC treatment. Ptosis was the initial symptom to show
improvement, while EOM dysfunction responded least favourably.
Conclusion: GDC coil packing appears to be an appropriate treatment method
for the relief of CN symptoms associated with intracranial aneurysms.
mbolization with Guglielmi detachable coils (GDC) has recently been ad-
vocated as a safe and less traumatic alternative for the treatment of in-
tracranial aneurysms, and is accepted as an effective and safe method for
preventing rehemorrhage of ruptured cerebral aneurysms (1). However, only a limited
number of reports have described the effects and outcome of endosaccular coiling of
aneurysms causing mass effects on cranial nerves (CN), and even less attention has
been given to the respective symptoms of CN dysfunction and its outcome after en-
dosaccular coil-packing treatment (2 4). The purpose of this article is to evaluate the
effect of intra-aneurysmal GDC coil packing on CN symptoms and signs, and also to
evaluate the responses of these to GDC treatment.
MATERIALS AND METHODS
Between March 1996 and August 2002, 218 patients with intracranial aneurysms
were treated by means of endosaccular GDC packing (Boston Scientific, Fremont,
Cal., U.S.A.) at our institution. Eighty of these patients had been treated for unrup-
tured aneurysms (including those found incidentally), for coincidental unruptured
aneurysms [in patients with aneurysmal subarachnoid hemorrhage (SAH)], or for
those in which mass effect had occurred. Among patients with unruptured aneurysms,
seven fulfilled the following criteria: 1) they had shown specific CN symptoms and
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Esigns consistent with the location of the aneurysm, and 2)
they had undergone endosaccular packing of aneurysms,
using GDC coils. Their medical records were analysed ret-
rospectively, and they were interviewed by telephone.
The following CN symptoms and signs were evaluated:
ptosis; diplopia, arising from oculomotor external ocular
muscle (EOM) dysfunction; mydriasis, in patients with ocu-
lomotor CN neuropathy; and lateral rectus EOM dysfunc-
tion in those with abducens CN neuropathy. The duration
of respective symptoms and signs prior to endovascular
treatment and the outcome of the respective signs were
evaluated, and the outcome was classified as improved, re-
solved, unchanged, or worsened. The time taken for CN
signs to show initial improvement after endovascular treat-
ment was determined, and clinical evaluations were per-
formed at preembolization, immediate post embolization,
monthly outpatient follow-up after embolization, and then
bimonthly and at the final outcome.
Aneurysms were assessed in terms of their location, size
(longest diameter), and the results of GDC treatment.
Location was classified as intradural or extradural, and size
as small ( 10 mm) or large (> 10 mm). GDC treatment
outcomes were categorized as complete, small neck rem-
nant, small aneurysmal remnant, or incomplete.
RESULTS
Table 1 summarizes the features observed at clinical pre-
sentation and the aneurysmal characteristics. All patients
were female, and their mean age was 63 years. The
aneurysms were located intradurally in four patients [inter-
nal carotid-posterior communicating artery (IC-Pcom)
(n=3); basilar bifurcation (n=1)], and extradurally [cav-
ernous internal carotid artery (ICA)] in three. Their mean
size was 11.5 mm and the mean follow-up period was 23
months.
Overall, two patients (29%) showed complete resolution
of all CN symptoms, three (43%) showed some improve-
ment, and in two (29%), symptoms were unchanged or
worsened.
The incidence of the respective CN signs according to the
location of the aneurysm is shown in Fig. 1. For IC-Pcom
aneurysms (n=3), ptosis and EOM dysfunction was present
in all patients, and mydriasis occurred in two. The basilar
bifurcation aneurysm (n=1) gave rise only to symptoms of
ptosis, while for cavernous ICA aneurysms (n=3), ab-
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Fig. 1. Incidence of cranial nerve signs according to aneurysm lo-
cation.
Note. EOM(III): extraocular muscle dysfunction, cranial nerve III,
IC-Pcom: internal carotid-posterior communicating artery
Table 1. Findings in Seven Patients with GDC-treated Unruptured Aneurysms Presenting with Cranial Nerve Signs 
Patient Age/Sex Location Size (mm) GDC Result Symptom Duration F/U Presenting Signs Improvement Noted at: Outcome
1 79/F IC-Pcom 09 neck 06 d 48 m Pt 2 m R
EOM (III) 2 m I
Myd N/A R
2 55/F IC-Pcom 09 neck 64 m 06 m Pt 4 m R
EOM (III) 6 m I
Myd 5 m I
03 74/F IC-Pcom 07 neck 06 d 03 m Pt 1 m I
EOM (III) U
4 71/F BABif 16 Inc 04 d 48 m Pt 1 m R
5 60/F C4-5 17 An 14 d 10 m Pt W
EOM (III) U
EOM (VI) U
6 62/F C4 10 Com 24 m 36 m EOM (VI) U
Pt   
7 42/F C5-PTA 13 An 01 m 01 m EOM (VI) 1 m R
Note. F/U: follow up, IC-Pcom: internal carotid-posterior communicating artery, BABif: basilar artery bifurcation, C: cavernous ICA,
PTA: persistent trigeminal artery, Com: complete, An: small aneurysmal remnant, Neck: small neck remnant, Inc: incomplete, D: days, M: months,
Pt: ptosis, Myd: mydriasis, EOM: extraocular muscle dysfunction, N/A: not available, R: resolved, I: improved, U: unchanged, W: worsened
*Transient development of mydriasis after treatment,    Newly developed after GDC treatmentducens EOM dysfunction was present in all patients and
ptosis and oculomotor EOM dysfunction in two and one,
respectively.
For CN signs, the final outcomes after GDC treatment
are indicated in Fig. 2. Both patients with mydriasis
showed clinical improvement or complete resolution, and
in four of six who presented with ptosis, the symptoms im-
proved or were resolved. The improvement or resolution
of oculomotor dysfunction was noted in two of four pa-
tients, and of abducens EOM dysfunction, in one of three.
The outcome of CN signs according to the size, duration
of symptoms and location of an aneurysm is summarized
in Table 2. For small aneurysms measuring 10 mm or less,
three of four patients with ptosis, two of three with oculo-
motor EOM dysfunction, and both with mydriasis showed
improvement or resolution of the respective CN signs, with
an overall incidence of improvement or resolution of 7/10
(70%). For aneurysms larger than 10 mm, however, im-
provement or resolution was noted in only one of two pto-
sis patients and one of two with abducens EOM dysfunc-
tion; the overall incidence of improvement or resolution
was 2/5 (40%).
Regarding the duration of pre-treatment symptoms, a
shorter duration (1 month or less) led to improvement or
resolution in three of four patients with ptosis, one of three
with oculomotor EOM dysfunction, the one with mydria-
sis, and one of two with abducens EOM dysfunction. The
overall incidence of improvement or resolution was 6/10
(60%). Where the duration of symptoms was longer (more
than 1 month), there was improvement or resolution in
one of two patients with ptosis, the ones with oculomotor
EOM dysfunction and mydriasis, but not in the one with
abducens EOM dysfunction. Three of five patients (60%),
in other words, experienced improvement or resolution of
their CN symptoms.
The improvement or resolution of symptoms also varied
according to location. Intradural aneurysms showed im-
provement or resolution in all four patients with ptosis, in
two of three with oculomotor EOM dysfunction, and in
both with mydriasis, an overall incidence of 8/9 (89%). For
extradural aneurysms, however, improvement or resolu-
tion was noted in only one of three patients with abducens
EOM dysfunction, an overall incidence of 1/6 (17%).
Among the oculomotor CN signs showing improvement,
ptosis seemed to show the earliest response, with improve-
ment beginning at a mean of two months after endovascu-
lar treatment (Fig. 3).
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Fig. 2. Outcome of cranial nerve signs after GDC treatment.
Note. EOM(III): extraocular muscle dysfunction, cranial nerve III
Fig. 3. Time taken for improvement of oculomotor cranial nerve
signs. Patient totals include only those in whom the time taken for
improvement or resolution was definite.
Note. EOM(III): extraocular muscle dysfunction, cranial nerve III
Table 2. Number of Patients Showing Improvement or Resolution of Respective Cranial Nerve Signs after GDC Treatment
Size Duration of Symptoms Location
Small ( 10 mm) Large (> 10 mm) Short ( 1 month) Long (> 1 month) Intradural Extradural
Total
Ptosis 3/4 1/2 3/4 1/2 4/4 0/2 4/6
EOM III 2/3 0/1 1/3 1/1 2/3 0/1 2/4
Mydriasis 2/2 0 1/1 1/1 2/2 0 2/2
EOM VI 0/1 1/2 1/2 0/1 0 1/3 1/3
Total 7/10 2/5 6/10 3/5 8/9 1/6
Note. EOM III: extraocular muscle dysfunction, cranial nerve IIIDISCUSSION
The surgical clipping of aneurysms causing CN symptoms
is known to be effective in relieving mass effect (5 8). In a
published report, analysis of the outcome of surgical man-
agement in unruptured aneurysms causing CN dysfunction
revealed that 41% of patients showed resolution or im-
provement, symptoms remained stable in 24%, and symp-
toms worsened or complications arose in 25% (4). Similar
or better results have been reported in endovascular treat-
ment using balloons or aneurysm coils in which CN dys-
function arose (2 4, 9). Unlike surgical clipping, endovas-
cular treatment does not immediately resolve the mass ef-
fect of an aneurysm; the loss or reduction of aneurysmal
pulsatility afforded by GDC embolization may, however,
be more important in the resolution of CN palsy caused by
cerebral aneurysms than in anatomic detachment of the
CN from an adjacent and adherent cerebral aneurysm by
clipping. In a series of 19 patients with CN dysfunction
who underwent treatment, Malisch et al. (4) reported com-
plete resolution in 32% of cases, improvement in 42%,
and no significant change or worsening in 26%, and our re-
sults (29%, 43%, and 29%, respectively) and theirs were
comparable.
With regard to the various CN symptoms and signs oc-
curring among our patients, ptosis was the most frequent
symptom, present in all patients with IC-Pcom and basilar
tip aneurysms, and two of three with a cavernous ICA
aneurysm. Mydriasis occurred in two of the three with IC-
Pcom aneurysms; its absence is considered an important
differential point between diabetic and aneurysm-related
oculomotor nerve neuropathy, and its absence in one pa-
tient in our series was unusual. An IC-Pcom aneurysm that
compresses the oculomotor nerve superomedially exerts
pressure on the dorsomedially-located irido-constrictor
fibers, causing mydriasis. In diabetic neuropathy, however,
impairment of the vasa vasorum leads to ischemic damage
to the central portion of the nerve, thus sparing pupillary
movement. The absence of mydriasis in oculomotor neu-
ropathies caused by IC-Pcom aneurysms, such as in our pa-
tient 3, has, however, been previously reported. The exis-
tence of a supplementary bundle of parasympathetic nerve
fibers coursing laterally through the nerve has been
demonstrated and it is these that sustain pupillary tone af-
ter the damage to dorsomedially-located fibers (5). In our
patient 3, ptosis improved after GDC treatment, indicating
that an aneurysm was the cause of the neuropathy.
Aneurysms located in the cavernous ICA are known to
cause a variety of CN III, IV, V, and VI dysfunctions (10,
11), and in some instances, the presenting symptoms may
vary according to the location and direction of the
aneurysm in relation to the course of the CN within the si-
nus.
Within the anterior cavernous sinus, superior orbital fis-
sure or posterior orbit, the oculomotor CN divides into a
superior ramus, which supplies the superior rectus muscle
and the levator muscle of the eyelid, and an inferior ramus,
which supplies the medial and inferior rectus muscles, the
inferior oblique muscle, and the ciliary ganglion (parasym-
pathetic fibers to pupillary constrictors). In the posterior
cavernous sinus, sympathetic nerve fibers send filaments to
the abducens CN, which traverses the lateral aspect of the
ICA. Compressive lesions in these respective areas may
lead to localized oculomotor or abducens CN dysfunction,
and Horner’s syndrome (12). In our series, abducens CN
dysfunction occurred in all cavernous aneurysms, while
oculomotor CN dysfunction was noted in patient 5 and af-
ter embolization in patient 6. Both these aneurysms had
anterior cavernous components, but in patient 7, the
aneurysm was located at the posterior genu of the cav-
ernous ICA, showing only abducens CN dysfunction.
The outcome of the various CN symptoms after em-
bolization varied according to the size of the aneurysm.
Where these were smaller ( 10 mm), the overall result
tended to be better than where they were larger (> 10
mm); the respective incidences of improvement or resolu-
tion were 7 of 10 (70%) and 2 of 5 (40%). Malisch et al.
(4) also reported better results for smaller aneurysms,
though the difference was statistically insignificant.
Outcome also varied according to location, tending to be
better for intradural aneurysms than extradural: the re-
spective incidences of improvement or resolution were 8/9
(89%) and 1/6 (17%). As far as we are aware, differences
of this kind have not previously been reported for GDC-
treated aneurysms. In the cases of extradural aneurysms
reported by Malisch et al. (4) (n=3; mean size, 18 mm;
mean duration of signs, 6 months; mean follow-up period,
33 months), and Halbach et al. (9) (n=14; mean size, 17
mm; mean duration of signs, 12 months; mean follow-up
period, 67 months), endosaccular treatment lead to im-
provement or resolution of CN symptoms in all cases. In
our series, however, the mean size of extradural
aneurysms was 13.3 mm (n=3; mean duration of signs, 8.5
months; mean follow-up period, 16 months), only slightly
larger than that of intradural aneurysms (10.3 mm). This
poorer outcome is difficult to explain but may in part be
due to our shorter duration of follow-up (33 months and
67 months, versus 16 months). Compared to the intradural
aneurysms in our series, intradrual aneurysms located in
the subarachnoid space may be more mobile and more vul-
nerable to pulsations than extradural cavernous
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cavernous sinus, thus resulting in a better outcome after
endosaccular embolization.
In both surgical and endovascular series, a shorter dura-
tion of CN symptoms prior to embolization is generally ac-
cepted as a factor for good prognosis (4, 5, 9), but in the lit-
erature, definitions of ‘short’ and ‘long’ durations of symp-
toms vary between 14 days and 12 months (4, 5). When
symptom durations were collapsed into ‘ 1 month’ and
‘> 1 month’, the authors could find no difference between
the groups.
The recovery of oculomotor CN function after surgical
treatment follows a predictable course: ptosis is frequently
the first ocular sign to subside, with recovery generally be-
ginning within the first month of surgery, and full recovery
taking several months. In our series, ptosis was the initial
symptom to show improvement, at about the second
month. Published reports have described more rapid reso-
lution of CN symptoms in ruptured aneurysms treated by
GDC coils (2, 3), and complete recovery of CN symptoms
as early as between one and three weeks has been claimed.
In our series, however, the outcome was neither as prompt
as this, nor as complete, findings which might be explained
in part by the fact that in the patients those reports de-
scribed, aneurysms were mostly intradural or small.
In patients with CN dysfunction who are recovering
from aneurysmal mass effect, the resolution of ptosis is
usually complete, whereas extraocular muscle function fre-
quently remains impaired (3); aberrant regeneration of the
oculomotor nerve has been suggested as a possible cause
(3, 12). In accordance with the findings of previous reports,
less than 50% of the patients with EOM dysfunction in our
series showed improvement or resolution.
An important limitation of our study is the small number
of patients included. Few earlier studies, however, have in-
vestigated the outcome of the various symptoms of each
CN sign, and to our knowledge, the series involved in this
current study is the largest to date to report these out-
comes in patients with unruptured aneurysms presenting
with CN deficits and treated with GDCs.
In conclusion, endosaccular GDC coil packing for
aneurysms which cause CN dysfunction is effective for the
treatment of CN symptoms. In our series, smaller ( 10
mm) or intradural aneurysms tended to show better re-
sults. Among the various CN signs, ptosis seems to be the
first to respond to endovascular therapy, while EOM dys-
function showed a slower and less favorable response.
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